Rally Foundation for Childhood Cancer Research shared a post on LinkedIn:
“A new drug offers hope to kids with cancer.
Rally Foundation first funded Dr. Jason Yustein at Baylor College of Medicine and continues to support his work today at Emory University. His team is making major progress against osteosarcoma, a bone cancer that grows fast and often returns after treatment. He identified a promising drug called Tegavivint, which is now moving through clinical trials to give kids and teens better options.
This is why early-stage research funding matters.
This is the impact of philanthropic seed investing.
This is Rally.
Give now.”
More posts featuring Rally Foundation for Childhood Cancer Research on OncoDaily.